Children's Hospital Colorado
Scott Sagel, MD, PhD

Scott Sagel, MD, PhD

Pulmonology - Pediatric, Pediatrics
Lung Disease, Cystic Fibrosis

Pulmonology - Pediatric, Pediatrics


Lung Disease, Cystic Fibrosis

"When I began treating kids with cystic fibrosis, I hoped my patients would live into adulthood; now, I expect it." 

- Dr. Scott Sagel

Get to know his background

I am interested in cystic fibrosis; primary ciliary dyskinesia; bronchiectasis; and nontuberculous mycobacteria infection.

Undergraduate 1992

University of Michigan (MI)

Medical School 1996

Washington University in St. Louis School of Medicine

Internship 1997

University of Colorado (Children's Hospital Colorado) Program

Residency 1999

University of Colorado (Children's Hospital Colorado) Program

Fellowship 2002

University of Colorado (Children's Hospital Colorado) Program, Pediatric Pulmonology

Graduate 2010

University of Colorado Denver

Member 2006

Society of Pediatric Research

Best Doctors in America 2007

5% of doctors selected nationwide by peers for the following years: 2007, 2009-11, 2014-2016.
Best Doctors in America

Denver's Top Doctors 2007

10 consecutive years (2007-2016)
5280 Magazine

Top Doctors (National) 2011

6 consecutive years (2011-2016)
US News & World Report

Golden Stethoscope Honoree 2013

For excellence in clinical education, 2010, 2013
University of Colorado

5-Star Award 2013

Score in the top 10 percent of patient-family experience of care surveys, 3 consecutive years (2013-2015)
Professional Research Consultants

Excellence in Patient Care Award 2016

For achieving 90% or higher with 9/10 ratings on Overall Provider Experience
Patient-Family Experience Awards

For Patients:
Dr. Sagel is a pediatrician who focuses on airway inflammation and lung disease in children with cystic fibrosis and primary ciliary dyskinesia. He serves as the director of the University of Colorado Cystic Fibrosis Center, as well as the lead site investigator for the National Institute of Health-funded Genetic Disorders of Mucociliary Clearance Consortium, a network dedicated to improving diagnostics and treatments for individuals with primary ciliary dyskinesia. Dr. Sagel’s research interests include: biomarkers of lung disease, including sputum and systemic markers of airway inflammation and injury; airway infections in cystic fibrosis including nontuberculous mycobacteria and the microbiome; and how bacterial pathogens relate to clinical outcomes in cystic fibrosis. Dr. Sagel’s research has been supported by the National Institutes of Health and the Cystic Fibrosis Foundation (CFF). An active member of the CFF, Dr. Sagel serves as co-chair of the CFF Biomarker Consortium and former chair of the Therapeutics Development Network Inflammatory Biomarkers Working Group. Dr. Sagel is Director of the NIH-funded University of Colorado Pediatric Clinical Translational Research Center Core Laboratory based at Children's Hospital Colorado and Director of the CFF-funded Center for Biochemical Markers.
For Referring Providers: